Ks logo

News & Insights

Subscribe
Icon search Icon close

  • People
  • OfficesIcon submenu
    • Icon submenu back back
    • Offices
    • North AmericaIcon submenu
      • Icon submenu back back
      • North America
      • Atlanta
      • Austin
      • Charlotte
      • Chicago
      • Denver
      • Houston
      • Los Angeles
      • Miami
      • New York
      • Northern Virginia
      • San Francisco
      • Silicon Valley
      • Washington, D.C.
    • Europe & Middle EastIcon submenu
      • Icon submenu back back
      • Europe & Middle East
      • Abu Dhabi
      • Brussels
      • Dubai
      • Frankfurt
      • Geneva
      • London
      • Paris
      • Riyadh
    • AsiaIcon submenu
      • Icon submenu back back
      • Asia
      • Singapore
      • Tokyo
  • CapabilitiesIcon submenu
    • Icon submenu back back
    • Capabilities
    • Corporate, Finance and InvestmentsIcon submenu
      • Icon submenu back back
      • Corporate, Finance and Investments
      • Overview
      • Activist Defense
      • Banking and Institutional Finance
      • Capital Markets
      • Construction and Procurement
      • Corporate Governance
      • Emerging Companies and Venture Capital
      • Employee Benefits and Executive Compensation
      • Energy and Infrastructure Projects
      • Financial Restructuring
      • Global Human Capital and Compliance
      • Investment Funds and Asset Management
      • Mergers and Acquisitions (M&A)
      • Middle East and Islamic Finance and Investment
      • Private Credit & Special Situations
      • Private Equity
      • Public Companies
      • Real Estate
      • Structured Finance and Securitization
      • Tax
      • Technology Transactions
    • Government MattersIcon submenu
      • Icon submenu back back
      • Government Matters
      • Overview
      • Antitrust
      • Data, Privacy and Security
      • Environmental, Health and Safety
      • FDA and Life Sciences
      • Government Advocacy and Public Policy
      • Government Contracts
      • Healthcare
      • International Trade
      • National Security and Corporate Espionage
      • Securities Enforcement and Regulation
      • Special Matters and Government Investigations
    • Trial and Global DisputesIcon submenu
      • Icon submenu back back
      • Trial and Global Disputes
      • Overview
      • Appellate, Constitutional and Administrative Law
      • Bankruptcy and Insolvency Litigation
      • Class Action Defense
      • Commercial Litigation
      • Construction and Engineering Disputes
      • Corporate and Securities Litigation
      • E-Discovery
      • Intellectual Property
      • International Arbitration and Litigation
      • Labor and Employment
      • Product Liability
      • Professional Liability
      • Toxic & Environmental Torts
    • Industries / IssuesIcon submenu
      • Icon submenu back back
      • Industries / Issues
      • Industries
      • Automotive, Transportation and Mobility
      • Energy
      • Financial Services
      • Food and Beverage
      • Franchise and Hospitality
      • Higher Education
      • Life Sciences and Healthcare
      • Technology
      • Issues
      • #MeToo
      • Buy American
      • COVID-19 Vaccine Rollout
      • Crisis Management
      • Environmental Agenda
      • Environmental, Social and Governance (ESG)
      • Focus on Women's Health
      • Russia/Ukraine
      • Special Purpose Acquisition Companies (SPACs)
      • The New Administration: Enforcement and Legislative Impact
  • CareersIcon submenu
    • Icon submenu back back
    • Careers
    • LawyersIcon submenu
      • Icon submenu back back
      • Lawyers
      • Experienced Lawyers
    • StudentsIcon submenu
      • Icon submenu back back
      • Students
      • Law Students
      • UK Graduate Recruitment
    • Judicial ClerksIcon submenu
      • Icon submenu back back
      • Judicial Clerks
      • Judicial Clerks
    • Other ProfessionalsIcon submenu
      • Icon submenu back back
      • Other Professionals
      • Other Professionals
  • News & InsightsIcon submenu
    • Icon submenu back back
    • News & Insights
    • NewsIcon submenu
      • Icon submenu back back
      • News
      • Cases & Deals
      • In the News
      • Press Releases
      • Recognitions
    • EventsIcon submenu
      • Icon submenu back back
      • Events
      • Conferences
      • Speaking Engagements
      • Webinars
    • InsightsIcon submenu
      • Icon submenu back back
      • Insights
      • Newsletters
      • Client Alerts
      • Thought Leadership
      • Articles
      • Feature
      • BLOGS
      • COVID-19 Vaccine Updates
      • China Subsidy Exchange
      • ESG Excellence
      • Energy Law Exchange
  • AboutIcon submenu
    • Icon submenu back back
    • About
    • Our FirmIcon submenu
      • Icon submenu back back
      • Our Firm
      • History
      • Our Values
    • Diversity & InclusionIcon submenu
      • Icon submenu back back
      • Diversity & Inclusion
      • Overview
      • Women’s Initiatives
      • Racial Diversity
      • LBGTQ+ Affinity
    • CitizenshipIcon submenu
      • Icon submenu back back
      • Citizenship
      • Overview
      • Pro Bono
      • Community Focus
  • Languages

News & Insights

  • NewsIcon submenu
    • Icon submenu back back
    • News
    • Cases & Deals
    • In the News
    • Press Releases
    • Recognitions
  • EventsIcon submenu
    • Icon submenu back back
    • Events
    • Conferences
    • Speaking Engagements
    • Webinars
  • InsightsIcon submenu
    • Icon submenu back back
    • Insights
    • Newsletters
    • Client Alerts
    • Thought Leadership
    • Articles
    • Feature
    • BLOGS
    • COVID-19 Vaccine Updates
    • China Subsidy Exchange
    • ESG Excellence
    • Energy Law Exchange
< Back to Bio
Icon close orange Brian A. Bohnenkamp

News 5 results

Recognition

June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation

Recognition

May 20, 2021
Chambers USA 2021 Names 179 K&S Lawyers and 65 K&S Practice Groups as Leaders in Their Fields

Recognition

June 15, 2020
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2020 Guide

Recognition

April 24, 2020
King & Spalding Earns Top Rankings in Chambers USA 2020 Guide

View all
Calendar view

Events 7 results

Webinar

November 9, 2021
King & Spalding Pharmaceutical University 2021

Webinar

September 9, 2021
14th Annual King & Spalding Medical Device Summit

Webinar

November 10, 2020
13th Annual King & Spalding Medical Device Summit

Speaking Engagement

August 6, 2020
Seth Lundy, Brian Bohnenkamp, Gina Cavalier, Terrence Burek to Speak on Webinar About Compliance in the Time of COVID

View all

Insights 17 results

Client Alert

April 25, 2022
COVID-19 Health Care Fraud Enforcement on the Rise: What’s Ahead for the Life Sciences & Healthcare Industries

Client Alert

March 28, 2022
AdvaMed Updates Code of Ethics on Interactions with HCPs: What’s the Impact on MedTech?

Client Alert

August 17, 2021
Revised PhRMA Code Provides Stricter Controls on HCP Speaker Programs

Client Alert

February 3, 2021
Implementation of Final Rule Excluding PBM Rebates from Discount Safe Harbor Delayed Until 2023

View all
© 2022 King & Spalding LLP
  • Contact Us
  • Disclaimer
  • Privacy Notice
  • Cookie Policy
  • Copyright Notice
  • Regulatory Notices
  • K&S Alumni Group